Latest Data & Signals Issued

Signal Type Signal Value Data
Score -4.732 3 days ( 7.87 % )
Last Price $11.83 -1.99 %
High/ Low $11.28 - $12.56 -0.177%
Chg 7 Days -11.91 % $13.43 $11.83
Chg 30 Days -2.47 % $12.13 $11.83
Chg 12 mos -50.95 % $24.12 $11.83
Trend - 3 mos -23.47 % Width: 39.53 %
Trend - 12 mos -18.52 % Width: 179.88 %
Pred. range - 3 mos $7.53 - $10.50 -36.38 % - -11.23 %
Pred. range - 12 mos $4.84 - $13.54 -59.11 % - 14.44 %
Short MA avg 3 mos Sell Jun 13, 2024 - 4 days
Long MA avg 3 mos Sell Jun 13, 2024 - 4 days
Short/Long MA avg 3 mos Sell Jun 17, 2024 - 2 days
Short MA avg 12 mos Sell Jun 14, 2024 - 3 days
Long MA avg 12 mos Sell May 06, 2024 - 31 days
Short/Long MA avg 12 mos Sell May 14, 2024 - 25 days
Pivot Short Sell Mar 28, 2024 - 57 days
Bollinger Buy Jun 11, 2024 - 6 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT